Neuberger High Yield Strategies Fund Inc. (NHS) Stock Score, Valuation & Financial Research
Neuberger High Yield Strategies Fund Inc. is in the Financial Services sector and Asset Management industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 61/100.
Quick answer for NHS
Neuberger High Yield Strategies Fund Inc. currently has a Wall Street Score of 61/100. The stored market price is $5.64. Its financial score is 16/100. Its valuation score is 100/100. These figures are a research snapshot, not a buy or sell recommendation.
What Neuberger High Yield Strategies Fund Inc. does
The Neuberger High Yield Strategies Fund Inc., identified by its symbol NHS, is a closed-end investment vehicle focused on fixed income. Established by Neuberger Berman LLC and overseen by Neuberger Berman Investment Advisers LLC, it allocates capital to debt instruments in global markets. The fund primarily targets high-yield bonds issued by companies across numerous sectors, such as automotive components and equipment, airlines, the broader automotive industry, electronics, healthcare services, packaging, integrated and service-based telecommunications, gaming, and natural gas distribution. Formed on July 28, 2003, and based in the United States, it was previously known as the Neuberger Berman High Yield Strategies Fund.
NHS financial snapshot
- Wall Street Score:
- 61/100
- Current price:
- $5.64
- Market capitalization:
- $177.0M
- Revenue:
- $49.3M
- Net income:
- $39.4M
- Free cash flow:
- $13.6M
- Cash:
- $7
- Total debt:
- $134.0M
- EPS:
- 1.17
- P/E ratio:
- 4.8x
- Financial score:
- 16/100
- Valuation score:
- 100/100
- Revenue score:
- 65/100
What stands out
- Reported year-over-year revenue growth is +0.8%.
- Free cash flow is $13.6M, showing positive cash generation.
- The balance sheet shows $7 of cash versus $134.0M of total debt, so leverage deserves attention.
- The current research record carries a listed fund vehicle warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 100/100, which Wall Street Score classifies as strong within the model's valuation framework.
The financial score is 16/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-07.
How to research NHS
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.